Global Blood Screening Market By Technology (Nucleic Acid Amplification Test (NAT), ELISA, Chemiluminescence Immunoassay (CLIA) & Enzyme Immunoassay (EIA), Next Generation Sequencing, and Western Blotting), By Product (Reagent and Instrument), By End-user (Independent Clinical Laboratories, Hospital-based Laboratories, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
Report Overview The Global Blood Screening Market size is expected to be worth around USD 6.4 billion by 2033 from USD 2.7 billion in 2023, growing at a CAGR of 9.0% during the forec...
